StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
8
This year
1
Publishing Date
2024 - 03 - 07
1
2023 - 10 - 19
1
2023 - 02 - 21
1
2023 - 01 - 13
1
2023 - 01 - 05
1
2022 - 12 - 19
1
2022 - 01 - 06
1
2021 - 12 - 09
1
Sector
Consumer non-durables
8
Health technology
4
Manufacturing
8
Tags
Acquire
8
Acquisition
27
Agreement
15
America
13
Biotech-bay
11
Brands
11
Business
12
Cancer
9
Cel
8
Ces
9
Collaboration
7
Commercial
7
Companies
11
Conference
10
Disease
11
Energy
44
Europe
15
Expansion
8
Expected
9
Fashion
13
Fda
8
Financial
30
Global
49
Group
27
Growing
14
Growth
87
Health
10
Insurance
9
International
13
Management
16
Marine
9
Maritime
11
Market
179
N/a
1063
Offering
13
One
8
Partnership
21
Platform
16
Pneumococcal
14
Positive
11
Potential
8
Program
14
Report
53
Research
37
Results
77
Retail
8
Sales
10
Security
8
Services
11
Set
10
Solutions
11
Study
14
Technology
13
Therapeutics
12
Total
12
Trends
10
Trust
10
Update
13
Vax-24
11
Year
17
Entities
Kering
8
Sutro biopharma, inc.
4
Vaxcyte, inc.
4
Symbols
ABBV
42
ABT
79
ACER
12
ADMA
18
ALPMF
17
ALPMY
17
AMGN
23
AMRX
15
ANIP
17
APYX
12
AQST
15
ARDX
11
ARVL
10
ATXI
10
BCLI
14
BDX
13
BGNE
16
BIIB
32
BLUE
13
BMRN
10
BMY
20
BNTX
24
BSX
11
CHRS
23
EGRX
11
EYEN
13
FBIO
14
FNCTF
63
GILD
21
GSK
14
INCY
23
IONS
13
JAGX
16
JNJ
226
LLY
71
MDT
28
MESO
15
MRK
36
MRNA
13
NVAX
11
NVO
11
NVS
28
NVSEF
22
OCGN
15
PFE
74
PRGO
90
REGN
50
RETA
12
SNGX
14
SNY
236
SNYNF
204
SRNE
21
TAK
17
TEVJF
22
TMO
16
TNXP
12
TTOO
14
VERU
14
VRCA
13
VRTX
14
Exchanges
Nasdaq
8
Crawled Date
2024 - 03 - 07
1
2023 - 10 - 19
1
2023 - 02 - 21
1
2023 - 01 - 13
1
2023 - 01 - 05
1
2022 - 12 - 19
1
2022 - 01 - 06
1
2021 - 12 - 09
1
Crawled Time
08:00
1
12:30
1
14:00
2
15:00
3
19:00
1
Source
www.biospace.com
4
www.globenewswire.com
2
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Fda
symbols :
Ppruf
save search
US FDA grants Orphan Drug Designation for iOnctura's first-in-class autotaxin cancer therapy
Published:
2024-03-07
(Crawled : 08:00)
- prnewswire.com
PPRUF
|
News
|
$361.9
37.56%
4.3K
|
Consumer Non-Durables
|
-20.02%
|
O:
-1.57%
H:
1.91%
C:
0.49%
PPRUY
|
News
|
$36.03
-0.11%
330K
|
Manufacturing
|
-19.74%
|
O:
-0.6%
H:
1.23%
C:
1.17%
fda
drug
cancer
designation
grants
therapy
Vaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-31 for the Prevention of Invasive Pneumococcal Disease in Adults
Published:
2023-10-19
(Crawled : 12:30)
- globenewswire.com
PPRUF
|
News
|
$361.9
37.56%
4.3K
|
Consumer Non-Durables
|
-17.42%
|
O:
-0.57%
H:
1.09%
C:
0.98%
PPRUY
|
News
|
$36.03
-0.11%
330K
|
Manufacturing
|
-15.86%
|
O:
1.4%
H:
0.53%
C:
-0.81%
PCVX
|
$60.65
-2.85%
-2.93%
660K
|
Health Technology
|
35.63%
|
O:
0.24%
H:
2.54%
C:
0.78%
STRO
M
|
$3.76
-1.05%
-1.06%
770K
|
Health Technology
|
7.95%
|
O:
-0.28%
H:
0.0%
C:
-6.27%
vax-31
fda
drug
disease
pneumococcal
clearance
application
Vaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-24 for the Prevention of Invasive Pneumococcal Disease in Infants
Published:
2023-02-21
(Crawled : 14:00)
- biospace.com/
PPRUF
|
News
|
$361.9
37.56%
4.3K
|
Consumer Non-Durables
|
-43.3%
|
O:
-3.64%
H:
3.09%
C:
1.33%
PPRUY
|
News
|
$36.03
-0.11%
330K
|
Manufacturing
|
-43.19%
|
O:
-1.68%
H:
1.12%
C:
-0.58%
PCVX
|
$60.65
-2.85%
-2.93%
660K
|
Health Technology
|
41.18%
|
O:
-0.93%
H:
1.96%
C:
0.55%
STRO
M
|
$3.76
-1.05%
-1.06%
770K
|
Health Technology
|
-38.91%
|
O:
-1.13%
H:
5.37%
C:
-0.98%
vax-24
fda
clearance
drug
disease
application
pneumococcal
TJP Labs Inc. Receives FDA Acceptance For Premarket Tobacco Product Application (PMTA)
Published:
2023-01-13
(Crawled : 15:00)
- prnewswire.com
PPRUF
|
News
|
$361.9
37.56%
4.3K
|
Consumer Non-Durables
|
-39.68%
|
O:
1.67%
H:
1.36%
C:
1.36%
PPRUY
|
News
|
$36.03
-0.11%
330K
|
Manufacturing
|
-39.75%
|
O:
0.03%
H:
1.91%
C:
1.65%
fda
application
Vaxcyte’s VAX-24 Granted FDA Breakthrough Therapy Designation for the Prevention of Invasive Pneumococcal Disease in Adults
Published:
2023-01-05
(Crawled : 15:00)
- biospace.com/
PPRUF
|
News
|
$361.9
37.56%
4.3K
|
Consumer Non-Durables
|
-32.19%
|
O:
1.3%
H:
2.07%
C:
1.45%
PPRUY
|
News
|
$36.03
-0.11%
330K
|
Manufacturing
|
-33.54%
|
O:
0.44%
H:
0.55%
C:
-0.17%
PCVX
|
$60.65
-2.85%
-2.93%
660K
|
Health Technology
|
33.23%
|
O:
-0.13%
H:
0.45%
C:
-1.58%
STRO
M
|
$3.76
-1.05%
-1.06%
770K
|
Health Technology
|
-53.09%
|
O:
-0.86%
H:
7.35%
C:
5.23%
vax-24
fda
designation
disease
granted
therapy
pneumococcal
Ubiquitome gets FDA authorization with Yale SARS-CoV-2 self-collection tests
Published:
2022-12-19
(Crawled : 14:00)
- biospace.com/
PPRUF
|
News
|
$361.9
37.56%
4.3K
|
Consumer Non-Durables
|
-30.83%
|
O:
-1.67%
H:
1.27%
C:
-1.25%
PPRUY
|
News
|
$36.03
-0.11%
330K
|
Manufacturing
|
-30.76%
|
O:
-0.81%
H:
0.12%
C:
-0.83%
fda
sars-cov-2
authorization
Vaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-24 for the Prevention of Invasive Pneumococcal Disease
Published:
2022-01-06
(Crawled : 15:00)
- biospace.com/
PPRUF
|
News
|
$361.9
37.56%
4.3K
|
Consumer Non-Durables
|
-55.66%
|
O:
2.64%
H:
0.0%
C:
-0.39%
PPRUY
|
News
|
$36.03
-0.11%
330K
|
Manufacturing
|
-56.36%
|
O:
-0.99%
H:
0.0%
C:
-1.16%
PCVX
|
$60.65
-2.85%
-2.93%
660K
|
Health Technology
|
161.1%
|
O:
4.14%
H:
2.57%
C:
-1.0%
STRO
M
|
$3.76
-1.05%
-1.06%
770K
|
Health Technology
|
-73.92%
|
O:
-20.18%
H:
0.0%
C:
-9.63%
vax-24
new drug
fda
clearance
application
drug
disease
fda clearance
pneumococcal
Hemp, Inc. Reports: Bipartisan Bill Demands FDA to Regulate Hemp-Derived CBD Food
Published:
2021-12-09
(Crawled : 19:00)
- globenewswire.com
PPRUF
|
News
|
$361.9
37.56%
4.3K
|
Consumer Non-Durables
|
-54.09%
|
O:
2.43%
H:
0.0%
C:
-0.68%
PPRUY
|
News
|
$36.03
-0.11%
330K
|
Manufacturing
|
-54.64%
|
O:
0.33%
H:
0.0%
C:
-0.55%
fda
ema
cbd
food
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.